Abstract
We constructed a genetically modified adenovirus vector incorporating an IgG Fc-binding motif from staphylococcal protein A, Z33 (Adv-FZ33). Adv-FZ33 allows an antibody to redirect the vector to a target molecule on the cell surface. We attempted to search for target antigen candidates and antibodies that allowed highly selective gene transduction into malignant tumors. Hybridoma libraries producing monoclonal antibodies (mAbs) were screened that increased transduction efficiency in cancer cell lines after cross-linking with Adv-FZ33. Target antigens of the mAbs were identified by immunoprecipitation and mass spectrometry. Of these mAbs, we noted a clone, F2-27, that recognized the receptor tyrosine kinase EphA2. Next, we generated an adenovirus vector, Ax3CMTK-FZ33, that expressed a herpes simplex virus thymidine kinase (HSV-TK). The therapeutic efficacy of F2-27-mediated HSV-TK gene transduction, followed by ganciclovir (GCV) administration, was studied in vitro. The inhibitory effect of F2-27 on cancer cell invasion was investigated by a three-dimensional spheroid formation assay. In vitro reporter gene expression after Adv-FZ33 infection via F2-27 was 146 times higher than with control mAb in EphA2-expressing cancer cell li...Continue Reading
References
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·M H St ClairP A Furman
Oct 10, 1997·Cell and Tissue Research·N W Gale, G D Yancopoulos
Oct 23, 1997·Current Opinion in Cell Biology·E B Pasquale
Apr 8, 1998·Annual Review of Neuroscience·J G Flanagan, P Vanderhaeghen
Jul 3, 2002·Nature Reviews. Molecular Cell Biology·Klas Kullander, Rüdiger Klein
Dec 21, 2002·International Journal of Cancer. Journal International Du Cancer·Tatsuya MiyazakiHiroyuki Kuwano
Jan 15, 2003·Journal of Virology·Christoph VolpersHanns Lochmüller
Jun 17, 2003·Journal of Cell Science·Keith K Murai, Elena B Pasquale
Jan 17, 2004·Clinical Chemistry·Christian HafnerThomas Vogt
Feb 20, 2004·Oncogene·Mark S DuxburyEdward E Whang
Jun 15, 2004·Current Opinion in Neurobiology·Yu Yamaguchi, Elena B Pasquale
Sep 11, 2004·Cancer Gene Therapy·Loren W NoblittSuresh K Mittal
Jun 2, 2005·Nature Reviews. Molecular Cell Biology·Elena B Pasquale
Aug 3, 2005·Journal of Cellular Biochemistry·Mikkel W PedersenHans S Poulsen
Oct 29, 2005·Molecular Cancer Research : MCR·Jill WykoskyWaldemar Debinski
Jun 17, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toshihiro TanakaHirofumi Hamada
Oct 17, 2006·Cancer·Najmunnisa NasreenVeena B Antony
Nov 2, 2006·Journal of the National Cancer Institute·Charles N LandenAnil K Sood
Mar 22, 2007·Molecular Cancer Research : MCR·Alice Bjerregaard LarsenHans Skovgaard Poulsen
Dec 15, 2007·The Journal of Clinical Investigation·Dana M Brantley-SiedersJin Chen
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jill WykoskyWaldemar Debinski
Jul 4, 2009·Cancer Cell·Hui MiaoBingcheng Wang
Dec 2, 2009·Cellular Signalling·Alice Bjerregaard LarsenHans Skovgaard Poulsen
Sep 3, 2013·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kazunori Kato